113 related articles for article (PubMed ID: 11092405)
21. The short-term effects of conjugated estrogen on bone turnover in older women.
Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG
J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949
[TBL] [Abstract][Full Text] [Related]
22. [Changes in bone and lipid metabolisms following oophorectomy and effects of estrogen replacement therapy].
Nozaki M; Hashimoto K; Sumii Y; Ogata R; Yuuki H; Yokoyama M; Imura M; Sano M; Nakano H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan; 45(1):38-44. PubMed ID: 8382249
[TBL] [Abstract][Full Text] [Related]
23. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia.
Hukkanen M; Platts LA; Lawes T; Girgis SI; Konttinen YT; Goodship AE; MacIntyre I; Polak JM
Bone; 2003 Feb; 32(2):142-9. PubMed ID: 12633786
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide donor alleviates ovariectomy-induced bone loss.
Wimalawansa SJ; De Marco G; Gangula P; Yallampalli C
Bone; 1996 Apr; 18(4):301-4. PubMed ID: 8726385
[TBL] [Abstract][Full Text] [Related]
25. Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats.
Wimalawansa SJ; Chapa MT; Yallampalli C; Zhang R; Simmons DJ
Bone; 1997 Sep; 21(3):275-80. PubMed ID: 9276093
[TBL] [Abstract][Full Text] [Related]
26. Variability and response of urinary resorption markers to hormone replacement therapy.
Garnero P; Delmas PD
J Bone Miner Res; 1999 Mar; 14(3):470-2. PubMed ID: 10027913
[No Abstract] [Full Text] [Related]
27. [Effect of vitamin K2 and estrogen administration on bone formation].
Aisaka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():484-7. PubMed ID: 15035176
[No Abstract] [Full Text] [Related]
28. Nitric oxide and bone.
Wimalawansa SJ
Ann N Y Acad Sci; 2010 Mar; 1192():391-403. PubMed ID: 20392265
[TBL] [Abstract][Full Text] [Related]
29. Differential time-related effects of conjugated equine estrogen on bone metabolism in oophorectomized women.
Nozaki M; Inoue Y; Hashimoto K; Ogata R; Nakano H
Int J Gynaecol Obstet; 1998 Jan; 60(1):41-6. PubMed ID: 9506413
[TBL] [Abstract][Full Text] [Related]
30. Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats.
Tsirella E; Mavrakanas T; Rager O; Tsartsalis S; Kallaras K; Kokkas B; Mironidou-Tzouveleki M
J Physiol Pharmacol; 2012 Apr; 63(2):201-4. PubMed ID: 22653908
[TBL] [Abstract][Full Text] [Related]
31. Oral, water-soluble combined estrogen/calcium preparation for postmenopausal therapy.
Downey D; Spencer SJ; Deghenghi R; Jaffe RB
Maturitas; 2001 Apr; 38(2):205-10. PubMed ID: 11306210
[TBL] [Abstract][Full Text] [Related]
32. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
Ouyang PC; Chow SN; Huang SC; Hsieh CY
Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
[TBL] [Abstract][Full Text] [Related]
33. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study.
Nabhan AF
Hum Reprod; 2006 May; 21(5):1320-4. PubMed ID: 16410328
[TBL] [Abstract][Full Text] [Related]
34. [Effect of suppletory estrogen or 1,25(OH)D3 on bone mineral content].
Amano K; Nemoto R; Kato Y; Masuda R; Nishijima M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):833-6. PubMed ID: 1500805
[TBL] [Abstract][Full Text] [Related]
35. Nitroglycerin ointment for the prevention of postmenopausal osteoporosis.
Beckett RD; Sheehan AH
Ann Pharmacother; 2011 Dec; 45(12):1566-70. PubMed ID: 22009995
[TBL] [Abstract][Full Text] [Related]
36. Compliance with estrogen hormone replacement therapy after oophorectomy: a prospective study.
Read MD; Edey KA; Hapeshi J; Foy C
Menopause Int; 2010 Jun; 16(2):60-4. PubMed ID: 20729495
[TBL] [Abstract][Full Text] [Related]
37. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen.
Nozaki M; Hashimoto K; Inoue Y; Ogata R; Okuma A; Nakano H
Int J Gynaecol Obstet; 1998 Jul; 62(1):69-75. PubMed ID: 9722129
[TBL] [Abstract][Full Text] [Related]
38. Bone turnover in young hypoestrogenic women on hormonal therapy.
Chan CC; Tang OS; Lau WN; Tang GW
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):204-6. PubMed ID: 16112793
[TBL] [Abstract][Full Text] [Related]
39. Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women.
Hayashi T; Ito I; Kano H; Endo H; Iguchi A
J Gerontol A Biol Sci Med Sci; 2000 Apr; 55(4):B183-90; discussion B191-3. PubMed ID: 10811145
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of bone turnover and bone mass during tapering estrogen therapy: a preliminary report.
Cantatore FP; Cicinelli E; Galantino P; Pepe V; Popolizio A; Savino F; Balzano G; Epifani S
Arthritis Rheum; 1995 Feb; 38(2):292-4. PubMed ID: 7848323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
